IRVINE, Calif. — Zymo Research and Star Array today announced Zymo Research’s strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore. The investment allows Zymo Research and Star Array to combine Zymo Research’s nucleic acid purification and assay technologies with Star Array’s engineering and automation expertise to expand into […]
With regards to ongoing communication in the media and Gusten Danielsson’s statement in Dagens Industri prompted by the fact that he recently chose to resign from his position, the Board of Directors has chosen to address the issue. Both the Board of Directors and management have intended to handle the situation professionally. There has been […]
NEWARK, Calif. — ATUM today announced a distribution partnership with Trio Biotech, Co Ltd. (TrioBio) to market and promote ATUM’s unique Leap-In Transposase® platform in China. ATUM’s Leap-In platform offers bioengineering solutions for efficient cell line development, genome engineering, and robust production of pharmaceutical biologics. TrioBio is well established in China as the premier distributor […]
BOSTON, United States and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA DDM™ Platform, securing its position as one of the largest knowledge sharing platforms connecting thousands of healthcare professionals and researchers across more than 70 countries. Founded in 2011, SOPHiA […]
With immediate effect, BICO’s CFO, Gusten Danielsson leaves the company and his role as CFO. A recruitment process for a new CFO has begun and for the time being, the VP of Finance, Tommy Niklasson will take responsibility for BICO’s finance department. “I would like to thank Gusten Danielsson for his great contribution and commitment from BICO’s start in 2016 […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to confirm finalization of a license agreement with Sumitomo Pharma Co., Ltd. (‘Sumitomo Pharma’) granting Sumitomo Pharma non-exclusive access to the fundamental CRISPR/Cas9 intellectual property portfolio held by ERS. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 […]
SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the completion of proof-of-concept demonstrations showing that its technology can be used effectively for encoding digital data in DNA sequences, and that the information that was stored could be retrieved accurately afterward. This validation is an important […]
NEWARK, Calif. — BioChain Institute, (“BioChain”) a leader in high-quality processed bio-sample products is excited to adopt GeoMx platform to provide digital spatial profiling services. BioChain announces partnership with Nanostring to provide Spatial Multiomics Services “It gives us a great sense of pride to include GeoMx into our portfolio of services,” said BioChain’s Director of Business […]
Seasoned Healthcare Executive Brings Extensive Life Sciences Experience to Company VERNON HILLS, Ill. — Antylia Scientific, a global leader of Molecular Diagnostic Reagents and Specialty Chemicals, Water and Air Quality Testing Equipment and Consumables, and Laboratory Products for the pharma, healthcare and environmental markets, announced today that Syed Jafry has joined its Board of Directors. Antylia is a […]
Hannover Medical School study will evaluate the use of whole-genome sequencing to show positive impact of earlier diagnosis and treatment for children with suspected genetic disorders SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced an agreement with Germany’s Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
